Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

If your desktop feels like a chaotic pile of open tabs, scattered chat apps, and forgotten logins, then let me introduce you ...

If you were to point to a single device responsible for much of Hackaday’s early success, it might be the Arduino Uno. The ...

In order to improve care for people with multiple sclerosis (MS), we need to understand more about their disease. The way we measure the impact of MS on daily life has remained relatively unchanged ...